T–cell–based immunotherapy for osteosarcoma: challenges and opportunities
AbstractEven though combining surgery with chemotherapy has significantly improved the prognosis of osteosarcoma patients, advanced, metastatic or recurrent osteosarcomas are often nonresponsive to chemotherapy, making development of novel efficient therapeutic methods an urgent need. Adoptive immun...
Main Authors: | Zhan Wang, Binghao Li, Yingqing Ren, Zhaoming Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00353/full |
Similar Items
-
Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
by: Zenan Wang, et al.
Published: (2019-05-01) -
Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
by: Zhong-Wei Luo, et al.
Published: (2020-12-01) -
Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy
by: Chen Chen, et al.
Published: (2019-02-01) -
Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma
by: Laurie Sorenson, et al.
Published: (2019-09-01) -
Curcumin-Loaded Nanoparticles Impair the Pro-Tumor Activity of Acid-Stressed MSC in an In Vitro Model of Osteosarcoma
by: Gemma Di Pompo, et al.
Published: (2021-05-01)